T1减影图对轻微强化儿童脑肿瘤强化成分勾画与体积的定量影响
结果显示加用减影图后所有肿瘤强化成分体积均增大,中位体积从3917 mm³增至9222 mm³(P<0.001),约三分之一病例体积增幅超过100%。
要点
- T1减影图可提高轻微强化儿童脑肿瘤强化成分的检出敏感性,建议在日常阅片中作为辅助序列
- 约三分之一病例加用减影图后强化成分体积增幅超过100%,可能影响手术范围和治疗反应评估
- 轻微强化病灶勾画存在观察者间一致性差的问题,减影图有助于提高勾画一致性和准确性
核心结论
- 使用T1减影图可测得更大的强化成分体积,三分之一的病例出现显著体积增加,提示减影图对轻微强化的检出敏感性更高
- 基于专家共识的结果支持将减影成像作为儿童神经肿瘤实践中治疗计划和反应评估的辅助工具进一步评价
研究设计与样本
- 将增强前T1加权图像与对应的增强后扫描图像进行配准,通过增强后减去增强前图像生成T1减影图
- 每个肿瘤勾画两次,第一次仅使用增强前和增强后T1加权图像,第二次加用T1减影图
- 强化成分由两名经认证的儿科神经放射学专家共识勾画,参考标准为专家共识勾画结果
关键影像表现/征象
- 加用T1减影图勾画后所有肿瘤的强化成分体积均较仅用平扫+增强图像时增大
- 体积变化按百分比分类:最小变化(<25%)8例,中等变化(25-100%)5例,显著变化(>100%)7例
诊断标准与关键数值
- 强化成分体积中位数从3917 mm³(IQR=13411)增加至9222 mm³(IQR=18474),P<0.001
- 体积百分比增加的平均值±标准差为181±317%,中位数为41.9%,范围为0.8-1143%
- 体积变化分类标准:最小变化定义为<25%,中等变化定义为25-100%,显著变化定义为>100%
- 体积变化分布:最小变化8例(40%),中等变化5例(25%),显著变化7例(35%)
临床应用与阅片要点
- 对轻微强化或强化不明确的儿童脑肿瘤,建议加用T1减影图辅助强化成分的勾画,以提高检出敏感性
- 强化成分体积的变化可能影响手术切除范围规划及按RAPNO指南进行的治疗反应评估
- 减影图有助于提高不同观察者间强化成分勾画的一致性,减少主观判断差异
局限性
- 原文未报告病例的病理类型分布,结果的普适性尚需进一步验证
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND AND PURPOSE: The delineation of contrast enhancement in pediatric brain tumors is crucial for effective surgical and treatment planning, as well as for monitoring treatment response per Response Assessment in Pediatric Neuro-Oncology (RAPNO) guidelines. Accurate delineation of enhancement is also important in ground truth generation for training automated deep learning models. However, many pediatric brain tumors frequently demonstrate borderline minimal to mild enhancement, which can be difficult to detect and lead to suboptimal reader agreement. This study aimed to quantitatively determine whether the use of T1-weighted subtraction maps during manual segmentation alters the measured volume of the enhancing component (EC) in mildly enhancing pediatric brain tumors.
MATERIALS AND METHODS: Twenty treatment-naïve pediatric brain tumor cases with mild enhancement were selected from the Children's Brain Tumor Network (CBTN) data set. Pre-contrast T1-weighted images were co-registered to their corresponding post-contrast scans, and subtraction maps were generated by subtracting pre-from post-contrast images. Tumors were then segmented twice: first using pre- and post-contrast T1-weighted images alone and then with the addition of T1 subtraction maps. In both cases, the EC was delineated based on the consensus of two board-certified pediatric neuroradiologists. EC volumes (mm³) were compared using the two-tailed Wilcoxon signed-rank test. Percent change in volume was calculated and categorized as minimal (<25%), moderate (25-100%), or substantial (>100%).
RESULTS: Segmentation incorporating T1 subtraction maps yielded larger EC volumes in all tumors. Median volume increased from 3,917 mm³ (IQR = 13,411) to 9,222 mm³ (IQR = 18,474), p<0.001. The mean ± SD percent increase was 181 ± 317% (median = 41.9%; range = 0.8-1,143%). Volume changes were minimal in 8 cases (40%), moderate in 5 (25%), and substantial in 7 (35%).
CONCLUSIONS: The use of T1 subtraction maps resulted in greater measured EC volumes, with substantial increases in one-third of cases. These findings, based on expert consensus, indicate improved sensitivity for detecting mild enhancement and support further evaluation of subtraction imaging as an adjunctive tool in pediatric neuro-oncology practice, to improve consistency and accuracy in treatment planning and response assessment.
引用
- Bagheri, Familiar, Adib Moradi, et al. Quantitative Impact of T1 Subtraction Maps on Enhancing Component Delineation and Measured Volumes in Minimally Enhancing Pediatric Brain Tumors. AJNR Am J Neuroradiol. 2026. PMID: 42342377. doi:10.3174/ajnr.A9497
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。